Quince Therapeutics (QNCX) director receives 2,700 stock options grant
Rhea-AI Filing Summary
Quince Therapeutics director Christopher J. Senner received a grant of 2,700 stock options for common stock. These options have an exercise price of $0.947 per share and expire on June 11, 2036. All 2,700 options vest on the one-year anniversary of the grant date, and 2,700 derivative securities are reported as held directly after the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Senner Christopher J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (Right to Buy) | 2,700 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Option (Right to Buy) — 2,700 shares (Direct)
Footnotes (1)
- F1. 100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date.
Key Figures
Stock options granted: 2,700 options
Exercise price: $0.947 per share
Options expiration: June 11, 2036
+1 more
4 metrics
Stock options granted
2,700 options
Director grant of derivative securities
Exercise price
$0.947 per share
Option strike price for common stock
Options expiration
June 11, 2036
Option term end date
Post-transaction derivative holdings
2,700 options
Total derivative securities held directly after grant
Key Terms
Director Stock Option, exercise price, vesting
3 terms
Director Stock Option financial
"security_title: "Director Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "0.9470" per share for the option"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"100% of the shares subject to this stock option will vest on the one-year anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Quince Therapeutics (QNCX) report for Christopher J. Senner?
Quince Therapeutics reported that director Christopher J. Senner received a grant of 2,700 stock options. These options relate to the company’s common stock and represent a compensation award rather than an open-market purchase or sale of existing shares.
What are the key terms of Christopher J. Senner’s new stock options at Quince Therapeutics (QNCX)?
The grant covers 2,700 stock options with an exercise price of $0.947 per share. The options are exercisable for Quince Therapeutics common stock and expire on June 11, 2036, providing a long-dated equity incentive to the director.
When do Christopher J. Senner’s Quince Therapeutics (QNCX) options vest?
According to the filing footnote, 100% of the 2,700 stock options will vest on the one-year anniversary of the grant date. This means no portion vests earlier, creating a single cliff vesting event after one year.
How many Quince Therapeutics (QNCX) derivative securities does Christopher J. Senner hold after this Form 4 transaction?
Following the grant, the Form 4 reports that Christopher J. Senner holds 2,700 derivative securities. These represent the newly granted stock options, all held directly, with no additional derivative positions shown in the filing’s derivative summary.
Is Christopher J. Senner’s Form 4 transaction a stock purchase or a compensation award at Quince Therapeutics (QNCX)?
The transaction is classified as a grant or award acquisition, not an open-market stock purchase. The options were granted at an exercise price of $0.947 per share, reflecting standard director equity compensation rather than a discretionary market trade.